Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition
Pfizer has won a $10 billion deal to acquire the fast-rising obesity drug developer Metsera, ending a fierce bidding war with Danish rival Novo Nordisk. Metsera accepted a sweetened offer…

